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Apoptosisa b s t r a c t
Murine regenerating (mReg) genes have been implicated in preserving islet cell biology. Expanding
on our previous work showing that overexpression of mReg2 protects MIN6 insulinoma cells against
streptozotocin-induced apoptosis, we now demonstrate that mReg2 induces glucose-regulated pep-
tide 78 (GRP78) expression via the Akt–mTORC1 axis and protects MIN6 cells against ER stress
induced by thapsigargin and glucolipotoxicity. Activation of mTORC1 activity results from both
mReg2-induced increased mTOR phosphorylation as well as increased expression of Raptor and
GbL. Inhibition of Akt and mTORC1 blunted the ability of mReg2 to induce GRP78 and attenuate
unfolded protein response (UPR). Knockdown of GRP78 sensitized the cells overexpressing mReg2
to UPR without affecting its ability to activate Akt–mTORC1 signaling. Induced expression of mReg2
may protect insulin producing cells from ER stress in diabetes.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction islet-derived protein III beta/PAP-I/HIP) which is found in pancre-Among the genes involved in preserving murine pancreatic islet
cell biology are those of the Regenerating (Reg) family. Transcrip-
tion of Reg genes have been shown to increase signiﬁcantly during
islet regeneration and recovery that occurs in the pancreas of
streptozotocin-induced diabetic mice and in partially pancreatec-
tomized mice undergoing exendin-boosted islet regeneration
[1,2]. For instance, Reg1 is elevated in serum of both type 1 and
type 2 diabetic patients [3] and islet cell-speciﬁc expression of
mReg2 and Reg3b occurs in response to adjuvant immunotherapy
[4] and in IGF-I knockout mice which display resistance to strepto-
zotocin-induced destruction of b-cells [1,5]. The mouse Regenerat-
ing protein 2 (mReg2, protein ID: NP_033069.1 = Q08731) also
known as Lithostathine 2, pancreatic thread protein (PTP2) and
pancreatic stone protein 2 (PSP2), is the sole member of the type
II subclass of the Reg family and found only in the mouse [6].
Growth of pancreatic b cells has been correlated with increased
expression of mReg2 in regenerating islets [4]. It is distinct from
mouse Reg3b (called Reg2 in the rat, also known as regeneratingatic acinar cells, intestinal enterocytes, and developing spinal
motoneurons [7]. We have previously reported the establishment
of stable clones of mouse insulinoma MIN6 cells that overexpress
mReg2 and their resistance to streptozotocin-induced apoptosis
[8].
The ER is the key organelle which provides a well regulated
environment for the folding and maturation of proteins entering
the regulated secretory pathway [9,10]. Peripheral insulin resis-
tance in type 2 diabetes contributes to chronic ER stress due to
increased insulin secretory demand and impaired glucose-stimu-
lated insulin secretion thereby evoking unfolded protein response
(UPR) and apoptosis of pancreatic b-cell [11–14]. The canonical
UPR signaling axis includes the activation of the ER-resident
type-I transmembrane protein kinases IRE1a, PERK and cleavage
of ATF6 [15–19]. Transiently activated UPR triggers adaptive
response to meet increased protein synthetic demand whereas
under conditions of chronic ER stress it activates stress pathways
leading to cellular apoptosis [20,21]. A key modulator of ER stress
response is glucose-regulated peptide 78 (GRP78) (also known as
BiP) which not only inhibits ER stress-induced changes in the
above UPR signal transducers [22] but also relieves translational
inhibition and promotes cell survival [23]. Minimizing ER stress-
induced UPR activation may, therefore, prevent b-cell loss.
In the present study we tested the hypothesis that mReg2 over-
expression may regulate GRP78 level and protect against UPR, and
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mReg2 (MIN6-mReg2) or the transfection vector (MIN6-VC). We
present evidence demonstrating that mReg2 attenuates ER
stress-induced UPR and apoptosis and that is protective action is
mediated by enhanced basal expression of GRP78 induced through
activation of Akt–mTORC1 signaling axis.
2. Materials and methods
2.1. Materials
MIN6 cells were obtained fromDr. J. Miyazaki (Osaka University,
Japan) (Miyazaki et al. 1990). Thapsigargin (Cat#586005) and
Rapamycin (Cat#553210) were obtained from Calbiochem (San
Jose, USA). MK-2206 (Cat#1888) was supplied by Cedarlane Can-
ada. Speciﬁc antibodies were procured from commercial sources
as indicated. Anti-pIRE1a (pSer724-speciﬁc (Cat#PA-1-16927),
anti-IRE1a (Cat#PA-1-16928) (Pierce); anti-pEIF2a (pS51 speciﬁc,
Cat#PV4810, Invitrogen), anti-EIF2a (Cat#sc11386, Santa Cruz);
rabbit mAbs against mTOR, pS2448mTOR included in the mTOR
pathway antibody sampler kit (Cat#9964,) p70 S6K (Cat#9202),
phospho-Thr389p70 S6K (Cat#9205) from Cell Signaling, anti-
GRP78 antibody (Cat#SPC-180, Stressmarq Biosciences, Victoria,
BC, Canada) and mAb against ATF (full length and cleaved/active
forms, Cat#IMG-273, Imgenex). ON-TARGET plus mouse Hspa5
(1428) GRP78 siRNA-SMARTpool (Cat#L-040337-00-0005) was
purchased from Ambion/Invitrogen). Annexin-V-Fluos (Cat#1 828
681) was purchased from Roche diagnostics (Montreal, Canada).
Sodium palmitate (Cat#P9767) was from Sigma Aldrich Canada.
2.2. Cell culture
Thedetails of transfection and establishment of stableMIN6 cells
expressingmReg2 (GenBank access number NM_009043) have pre-
viously been reported [8]. The overexpression of mReg2 in stably
selected clones was documented previously by RT-PCR and immu-
noblot analysis using anti-mReg2 antibody [8]. MIN6-VC and
MIN6-mReg2 cells were sub-cultured at a density of 2  104 cells/
cm2 in 6well plates andmaintained at 37 C, 5% CO2 in a humidiﬁed
atmosphere in DMEM containing 10% heat-inactivated FBS, 30 lM
b-mercaptoethanol, and antibiotic–antimycotic. The cells were
treated with 1 lM thapsigargin (Tg) for the indicated times. For
experiments involving palmitate treatment, the fatty acid was
dissolved at a concentration of 100 mM in 50% ethanol, diluted
200-fold in culture medium (ﬁnal concentration of 0.5 mM) and
then allowed to complex with 0.5% fatty acid free BSA prior to use.
2.3. Immunoblot analysis
Whole cell lysates were prepared from cells incubated in the
absence or presence of Tg by solubilizing in lysis buffer containing
20 mM Tris–HCl (pH 8), 1% Triton X-100, 150 mM NaCl and prote-
ase inhibitor cocktail (Roche Diagnostics) for 10 min on ice, soni-
cated and centrifuged at 20000g. Protein concentration in the
extracts was determined by the Bio-Rad assay in a Bio-Tek micro-
plate reader.
Equal amount (50 lg) of protein extracted from each sample
along with protein molecular weight markers (Bio-Rad) were sub-
jected to electrophoresis on SDS–polyacrylamide (12%) gels and
transferred onto nitrocellulose membranes. After blocking with
5% (w/v) non-fat milk, the membranes were probed with primary
antibodies as indicated followed by incubation with horseradish
peroxidase-conjugated secondary antibody and hypersensitive
enhanced chemiluminescence reagent (Lumigen TMA-6), and the
signals captured using an Alpha Innotech FluorChem 8800 Imager
(San Leandro, CA).2.4. Measurement of apoptosis
UPR-induced apoptosis was monitored by dual label ﬂow
cytometry in cells incubated in the absence or presence of 1 lM
Tg for 4 h following staining with annexin-V-Fluos and PI. Apopto-
tic cells were quantiﬁed on the basis of their ability to display
increased annexin-V-Fluos labeling in the absence of PI uptake as
previously reported [8,24].
2.5. Quantitative reverse transcription PCR analysis
Total RNA was extracted from cells using RNeasy Plus Mini Kit
(Cat#74134, Qiagen). The RNA expression level was evaluated by
two step real time PCR in a Roche Light Cycler. First, 1 lg RNA
was converted into cDNA using reverse transcriptase (#205311,
Qiagen) in a 20 ll reaction volume. Second, real time PCR was per-
formed with SYBR (#330601, ASA Biosciences) using 1 ll of this
solution (equivalent to 50 ng initial RNA). The expression of
GRP78 was assessed by qRT-PCR using the following primers:
forward 50-AGACTGCTGAGGCGTATTTGGGAA-30 and reverse
50-AGCATCTTTGGTTGCTTGTCGCTG-30. GRP78 mRNA levels were
normalized to the actin mRNA levels, the expression of which
was monitored using the primers forward 50-GCTACAGCTTCAC-
CACCACA-30 and reverse 50-TCTCCAGGGAGGAAGAGGAT-30.
2.6. Silencing of GRP78 expression by siRNA strategy
MIN6-mReg2 cells were transiently transfected with ON-TAR-
GET plus mouse GRP78 siRNA SMARTpool or scrambled siRNA con-
trol using Lipofectamine RNAiMAX (Invitrogen). GRP78 expression
was assessed at the mRNA and protein levels in cells 36–48 h after
transfection by qRT-PCR and Western blot analyses respectively.
2.7. Statistical analysis
All values are expressed as the means ± S.E.M. Statistical analy-
ses of the difference between groups were performed using one-
way analysis of variance and student’s t-test using the Sigmaplot
11.0 software. P < 0.01 was considered signiﬁcant.
3. Results
3.1. Overexpression of mReg2 attenuates Tg-induced ER stress in MIN6
cells
We ﬁrst compared the ability of Tg to induce UPR by assessing
the phosphorylation of IRE1a and eIF2a, two canonical transducers
of the UPR in MIN6-VC and in two independent clones of
MIN6-mReg2 cells. MIN6-VC cells displayed robust UPR in
response to ER stress induced by exposure to Tg (1 lM) for 4 h as
evidenced by >3-fold increase in the phosphorylation of both
IRE1a and eIF2a (Fig. 1A). We also observed a rapid and time-
dependent increase in the phosphorylation of both IRE1a and
eIF2a in response to exposure to Tg in MIN6-VC cells whereas both
proteins were phosphorylated to a considerably less extent in
MIN6-mReg2 cells at each of the time point tested (Fig. 1B). UPR
induced by Tg at lower doses of 0.1–0.5 lM was detectable in
MIN6-VC cells but not in MIN6-mReg2 cells at these time points
(data not shown).
3.2. ATF6 cleavage in MIN6 cells is attenuated by overexpressed mReg2
ER stress is also known to trigger the cleavage and activation of
ATF6. This was indeed the case in MIN6-VC cells treated with Tg
(Fig. 2). By contrast, as shown in this ﬁgure, ATF cleavage was sig-
niﬁcantly blunted in MIN6-mReg2 cells providing further evidence
Fig. 1. Unfolded protein response in Tg treated MIN6 cells is attenuated by mReg2.
(A) Following incubation with 1 lM Tg for 4 h, UPR was detected by the increase in
phosphorylation of IRE1a and eIF2a in MIN6-VC cells whereas phosphorylation of
both proteins was considerably less in two independently established clones of
MIN6-mReg2 cell lines (prepared by independent transfection with pcDNA3.1-
mReg2 vector and selection for antibiotic resistance as reported in ref 30.). (B and C)
MIN6-VC cells displayed a time-dependent increase in the phosphorylation of
IRE1a and eIF2a in response to treatment with Tg (1 lM). By contrast phosphor-
ylation of both proteins was attenuated in MIN6-mReg2 cells incubated with Tg.
The total levels of IRE1a and eIF2awere unaffected in the corresponding samples as
shown (blots representative of 4 separate experiments).
Fig. 2. ER stress-induced cleavage of ATF6 is attenuated by overexpressed mReg2.
Generation of the 50 kDa cleaved fragment of ATF6 was seen in MIN6-VC cells
treated with Tg for 4 h. By contrast, cleavage of the full length ATF was inhibited in
MIN6-mReg2 cells (blots representative of 4 separate experiments).
Fig. 3. Tg-induced apoptosis occurs in MIN6-VC, but not in MIN6-mReg2 cells.
Following incubation in the absence or presence of Tg (1 lM) for 4 h, cells were
stained with PI and annexin-V-FITC and apoptotic cells displaying increased
annexin-V-FITC labeling in the absence of PI uptake was assessed by dual label ﬂow
cytometric analysis. (A) 4.2 ± 0.6-fold increase (⁄P < 0.01) in apoptotic cells was
detected in Tg-treated MIN6-VC cells relative to that seen in untreated controls. By
contrast, no detectable increase in apoptosis was seen in MIN6-mReg2 cells which
were resistant to Tg-induced ER stress. Values shown are (mean ± S.E.M., n = 12).
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induced ER stress.
3.3. Tg treatment induces apoptosis in MIN6-VC but not in MIN6-
mReg2cells
Tg-induced ER stress is known to trigger apoptosis in pancreatic
b-cells [25]. In accordance with this we found that 17.4 ± 1.8% of
MIN6-VC cells became apoptotic following 4 h Tg treatment, a
4-fold increase compared to the background level seen in cells
not exposed to Tg (P < 0.01, n = 12, Fig. 3). By contrast, no
detectable increase in apoptosis was observed in Tg-treated
MIN6-mReg2 cells consistent with the ﬁnding that these were
displayed attenuated-UPR.
3.4. mReg2 overexpression protects MIN6 cells against UPR induced by
high glucose and palmitate
UPR induced by high glucose and palmitate which exert ER
stress and is of relevance in type 2 diabetes [26,27]. Incubation
of MIN6-VC cells in presence of 25 mM glucose for 24 h led to arobust ER stress response as evidenced by increase in IRE1a phos-
phorylation. In cells treated with palmitate in presence of high glu-
cose we observed a further increase in IRE1a phosphorylation
(Fig. 4). By contrast, the phosphorylation of IRE1a remained rela-
tively unaltered in cells incubated in the absence or presence of
palmitate in medium containing 5.5 mM glucose. As shown in this
ﬁgure, in MIN6-mReg2 cells the ability of high glucose ± palmitate
to induce IRE1a phosphorylation was markedly reduced.
3.5. Overexpression of mReg2 enhances the basal expression of GRP78
Attenuation of the UPR signaling events in mReg2 overexpress-
ing MIN6 cells prompted us to examine the levels of GRP78, the ER
Fig. 4. Overexpression of mReg2 attenuates UPR induced by high glucose and
palmitate in MIN6 cells. Occurrence of UPR in MIN6-VC cells incubated for 24 h in
medium containing high glucose [25 mM] ± 50 mM palmitate is evidenced by the
marked increase in IRE1a phosphorylation in MIN6-VC cells. By contrast, IRE1a
phosphorylation did not increase in MIN6-mReg2 cells in response to high
glucose ± palmitate.
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brane ER stress sensors and promotes cell survival [28,29].
Quantitative RT-PCR analysis performed using RNA isolated from
MIN6-VC cells in unstressed condition showed minimal basal
expression of GRP78 mRNA whereas it was 5.9 ± 0.8-fold higher
in MIN6-mReg2 cells (Fig. 5A, compare bars 1 and 3). Tg induced
ER stress induced a 4-fold increase in GRP78 mRNA in MIN6-VC
cells. Expression of GRP78 in MIN6-mReg2 cells also increased by
Tg-induced ER stress to a level that was 2.5-fold greater than that
seen in MIN6-VC cells (compare bars 2 and 4). We veriﬁed that
mReg2-induced increase in GRP78 at the mRNA level was paral-
leled by an increase at the protein level by Western blot analysis
(Fig. 5B). Tg-induced ER stress did not affect the expression of
mReg2 in both cell lines (data not shown).Fig. 5. mReg2 enhances the expression of GRP78 in MIN6 cells. Cells were
incubated in the absence and presence of 1 lM Tg for 4 h and the expression of
GRP78 at the mRNA and protein levels were assessed. (A) Quantitative RT-PCR
analysis revealed a low level expression of GRP78 mRNA under basal conditions in
MIN6-VC cells whereas it was 5.9 ± 0.8-fold higher in MIN6-mReg2 cells (compare
bars 1 and 3, ⁄⁄P < 0.01). There was a 4.1 ± 0.9-fold increase in response to Tg (1 lM
Tg for 4 h) – induced ER stress in MIN6-VC cells (compare bars 1 and 2, ⁄⁄P < 0.01) In
MIN6-mReg2 cells Tg treatment elicited a 2.5-fold induction in GRP78 mRNA over
that seen in MIN6-VC cells (compare bars 2 and 4, ⁄⁄P < 0.01). Values represent the
ratio of GRP78 to actin mRNA values in each sample (mean ± S.E.M., n = 6). (B)
Immunoblot demonstrating the increased expression of GRP78 protein in MIN6-
mReg2 cells compared to that seen in MIN6-VC cells incubated in the absence and
presence of Tg for 8 h (data representative of three independent experiments).3.6. mReg2 overexpression promotes phosphorylation of Akt and
mTOR and activation of mTORC1
Since GRP78 expression has been shown to be regulated by the
Akt–mTORC1 signaling axis, we evaluated the stimulatory effect of
mReg2 overexpression on these kinases. First we observed that the
basal phosphorylation status of Ser473Akt and Ser2448mTOR was
higher in MIN6-mReg2 cells (1.7 ± 0.05 and 1.5 ± 0.07-fold respec-
tively) than in MIN6-VC cells (n = 4, P < 0.01, Fig. 6A and B). The
levels of total Akt and mTOR were comparable in both cell lines.
The ability of mReg2 to activate mTORC1 suggested by these
ﬁndings was veriﬁed by the increase in phosphorylation of its sub-
strate p70 S6K under basal conditions in MIN6-mReg2 cells
(Fig. 6C).
3.7. mReg2 overexpression increased the expression of Raptor and GbL,
constituents of the active mTORC1 complex
The phosphorylation of p70 S6K under basal conditions in
MIN6-mReg2 cells was far greater than that expected from the
modest increase in the phosphorylation of mTOR. This raised the
possibility that this may result from increased presence of the
rapamycin-sensitive adaptor protein of mTOR (Raptor) and the G
protein b-subunit-like protein (GbL), which are essential constitu-
ents of mTORC1 kinase complex. Indeed, immunoblot analysis
revealed 2.2- and 1.6-fold increases respectively in the basal
expression of Raptor and GbL in MIN6-mReg2 cells compared to
that seen in MIN6-VC cells (Fig. 6D and E). GbL can also interact
with Rictor (rapamycin-insensitive companion of mTOR) to gener-
ate the active mTORC2 kinase complex. We found that Rictor level
in MIN6 cells was not induced by mReg2 overexpression (Fig. 6 D),
and no change in the phosphorylation of PKCa, a target of mTORC2
kinase was observed (not shown) suggesting that mTORC2 is not
involved in mReg2-mediated cytoprotective actions.
3.8. Inhibition of Akt and mTORC1 attenuates the increased basal
expression of GRP78 and sensitizes MIN6-mReg2 cells to ER stress-
induced apoptosis
In order to conﬁrm that mReg2-mediated activation of Akt and
mTORC1 is essential for increased basal expression of GRP78, we
compared its levels in MIN6-mReg2 cells incubated in the absence
and presence of inhibitors of Akt (MK-2206) or mTORC1 (rapamy-
cin). The expression of GRP78 mRNA level relative to that of actin
in MIN6-mReg2 cells pretreated with MK-2206 and rapamycin for
12 h decreased by 29 ± 6% and 22 ± 4% respectively (P < 0.01,
Fig. 7A). Immunoblot analysis revealed that GRP78 protein level
in MIN6-mReg2 cells also decreased in response to the inhibition
of Akt and mTORC1 (Fig. 7B). Tg-induced ER stress was also
observed incubated in the presence, but not absence, of these
inhibitors as evidenced by the increase in phosphorylation of both
IRE1a and eIF2a (Fig. 7C). As shown in this ﬁgure, pretreatment of
MIN6-mReg2 cells with MK-2206 or rapamycin also suppressed
GRP78 levels and led to increased apoptosis (Fig. 7D). Pretreatment
with MK-2206 or rapamycin also sensitized MIN6-mReg2 cells to
UPR induced by glucolipotoxicity. This was indicated by the
increase in IRE1a phosphorylation in the presence of either inhib-
itor (Fig. 8). Knockdown of GRP78 utilizing si-RNA strategy was
used to further conﬁrm its role in mediating the protective effect
of mReg2 against ER stress response and UPR-induced apoptosis.
In cells treated with GRP78-speciﬁc siRNA we observed a signiﬁ-
cant reduction of GRP78 expression at both mRNA and protein lev-
els compared to cells exposed to scrambled siRNA (Fig. 9A). As
expected, knockdown of GRP78 led to a greater Tg-induced ER
stress response and was reﬂected in the marked increase in IRE1a
phosphorylation (Fig. 9B). As shown in this ﬁgure, knockdown of
Fig. 6. mReg2 overexpression in MIN6 cells increases basal phosphorylation of Akt and mTORC1, mTORC1 activity and Raptor and GbL. Phosphorylation status of Akt and
mTOR in lysates of cells incubated in the absence and presence of 1 lM Tg for 4 h were assessed by immunoblot analysis. (A) The ratios of phsoho473Akt to Akt revealed a 1.6-
fold increase in MIN6-mReg2 cells compared to MIN6-VC cells (⁄⁄P < 0.01, n = 4). (B) The ratios of mTOR Ser2448 to mTOR was 1.4-fold higher in MIN6-mReg2 cells while mTOR
level was comparable to that seen in MIN6-VC cells (⁄⁄P < 0.01). (C) The basal activity of mTORC1 kinase complex was signiﬁcantly higher in MIN6-mReg2 cells as seen from
the marked increase in the basal phosphorylation level of Thr389 in p70 S6K compared to that detected in MIN6-VC cells (blots representative of 4 independent experiments).
(D) Western blot analysis revealed an increase in level of Raptor and GbL, constituents involved in the formation of active mTORC1 kinase complex in MIN6-Reg2 cells relative
to that found in MIN6-VC cells. By contrast, mReg2 did not affect the level of Rictor, a constituent required for mTORC2 kinase complex. (E) Quantitation of the band
intensities corrected to that of actin revealed a 1.6-fold increase in Raptor in MIN6-Reg2 cells compared to MIN6-VC cells (n = 4, ⁄⁄P < 0.01) and a 1.4-fold increase GbL in
MIN6-Reg2 compared to MIN6-VC cells (n = 4, ⁄⁄P < 0.01).
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ylation and mTORC1 activity. These data thus indicate that the
upregulation of GRP78 expression by mReg2 is signaled via Akt–
mTORC1 signaling axis.
4. Discussion
In this study we demonstrate that mReg2 overexpression pro-
tects MIN6 cells against UPR triggered by Tg, a chemical inducer
of ER stress as well as by saturated fatty acid and high glucose.
The greater basal expression of GRP78 correlated with the lower
susceptibility of MIN6-mReg2 cells to Tg-induced UPR. Further-
more, MIN6-mReg2 cells displayed increased phosphorylation of
(Ser473) Akt and (Ser2448) mTOR in addition to increased basalexpression of Raptor and GbL which are essential components of
the active mTORC1 kinase complex. Pretreatment of MIN6-mReg2
cells with inhibitors of Akt and mTORC1 as well as direct knock-
down of GRP78 through RNA-interference technique attenuated
the ability of mReg2 to increase the basal expression of GRP78
and sensitized the cells to Tg- and palmitate-induced ER stress
and apoptosis. These ﬁndings demonstrate that mReg2 protects
MIN6 cells against ER stress by enhancing the basal expression of
GRP78 through the Akt–mTORC1 signaling axis.
The cellular response to adapt to increased protein synthesis
and restore ER homeostasis is mediated by the multifunctional
ER chaperone protein GRP78 which acts as a sensor of ER stress-
induced UPR. The canonical UPR signaling axis includes the
phosphorylation-dependent activation of the ER-resident type-I
Fig. 7. Inhibition of Akt or mTORC1 abrogates mReg2-induced GRP78 expression which leads to increase in Tg-induced ER stress response and apoptosis. MIN6-mReg2 cells
were incubated for 24 h in the absence or presence of Akt inhibitor MK-2206 (1 lM) or rapamycin (10 nM). (A) Quantitative RT-PCR analysis revealed that GRP78 mRNA
expression relative to that of actin decreased by 29 ± 6% and 23 ± 4% respectively in cells exposed to the Akt inhibitor MK-2206 and mTORC1 inhibitor rapamycin (n = 4,
⁄P < 0.01). (B) Immunoblots demonstrating the decrease in GRP78 protein levels in MIN6-Reg2 cells by 43 ± 6 and 32 ± 3 respectively treated with MK-2206 and rapamycin
compared to untreated controls (n = 4, P < 0.01). Loading accuracy was monitored by reprobing the blots for actin (blot representative of four independent experiments). (C)
Inhibition of Akt and mTORC1 increases phosphorylation of IRE1a and eIF2a in response to Tg-induced ER stress in MIN6-mReg2 cells. (D) Pretreatment with either MK-2206
or rapamycin sensitizes MIN6-mReg2 cells to Tg-induced, ER stress-mediated, apoptosis as evidenced by an increase (3.3 ± 0.6 and 2.8 ± 0.8-fold respectively) in the number
of apoptotic cells (⁄P < 0.01, n = 6).
Fig. 8. Inhibition of Akt–mTORC1 signaling axis sensitizes MIN6-mReg2 cells to
palmitate-induced UPR response. MIN6-mReg2 cells were incubated in medium
containing 25 mM glucose and 0.5 mM palmitate in the absence and presence of
MK-2206 or rapamycin for 24 h. Increased UPR response was observed in cells
incubated in the presence of either inhibitor as shown by the increase in IRE1a
phosphorylation (blot representative of 3 separate experiments).
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[15–19]. GRP78 not only inhibits ER stress-induced changes in the
above UPR signal transducers [22] but also relieves translational
inhibition and promotes cell survival [23]. Moreover, binding of
GRP78 to misfolded proteins promotes their proper folding or
direct them to degradation [21,22,34,35]. ER stress-induced
cellular toxicity has been linked to upregulation of GRP78 throughactivation of mTORC1, a kinase which can trigger either cell growth
or cell death depending on the level of UPR activation [30,31]. Tg
treatment increases GRP78 level in response to ER stress in both
MIN6-VC and MIN6-mReg2 cells in agreement with a previous
report of ER stress-induced increase in GRP78 in mouse insulinoma
cells [36]. UPR can occur in response to physiological stimuli such
as nutrient load and growth signals and, under favorable growth
conditions, is inversely dependent on mTORC1 activation [21].
However, in pathological conditions UPR-induced cell toxicity
has been linked to chronic activation of mTORC1 [30–32]. Such
interplay between UPR and mTORC1 has been implicated in
glucolipotoxicity-triggered pancreatic b-cell demise as well as in
diabetic nephropathy [30,33]. The increased basal GRP expression
and the attenuation of UPR in MIN6-mReg2 cells support the
notion that the abundance of GRP78 is critical for regulating ER
stress response. Relevant in this context is the reported attenuation
of UPR due to elevated basal GRP78 expression induced by ER
stress-independent activation of mTORC1 pathway resulting from
the ablation of proliferator-activated receptor gamma coactiva-
tor-1b (PGC1b) or by IGF-I receptor activation [37,38].
In the present study we observed that mTORC1 activity, as evi-
denced by the several fold increase in its ability to phosphorylate
p70 S6K, was far greater than that expected from the modest
increase in mTOR phosphorylation alone. Our ﬁnding that
Fig. 9. Knockdown of GRP78 expression by siRNA abrogates the protective effect of mReg2 against Tg-induced ER stress response but not its ability to promote Akt
phosphorylation and mTORC1 activity. (A) MIN6-Reg2 cells were transfected with either ON-TARGET plus mouse GRP78 siRNA SMARTpool or scrambled siRNA control as
described under Section 2. Signiﬁcant reduction in GRP78 mRNA expression (⁄⁄P < 0.001, n = 3) was observed which correlated with a signiﬁcant decrease in GRP78 protein
level as shown by Western blot analysis (insert, blot representative of 3 separate experiments). (B) MIN6-Reg2 cells transfected with GRP78-speciﬁc and scrambled control
siRNAs were treated with 1 lM Tg for 4 h and cell extracts were subjected to Western blot analysis. Knockdown of GRP78 abrogated the protective effect of mReg2 on Tg-
induced ER stress as evidenced by the increase in IRE1a phosphorylation but not its ability to induce Akt phosphorylation and mTORC1-mediated increase in p70S6K
phosphorylation.
Fig. 10. Proposed model of mReg2-induced attenuation of ER stress-induced UPR in
MIN6 cells. Increase in GRP78 in response to mReg2 activated Akt–mTORC1
signaling attenuates Tg-induced UPR in MIN6-mReg2 cells.
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essential constituents of mTORC1 complex [39,40] suggests that
they may contribute to stabilizing and or increasing its kinase
activity. The critical role of Raptor in this complex is illustrated
by the fact that its conditional knockdown abolishes mTORC1
activity [41,42]. While a decrease in Raptor expression has been
demonstrated in paclitaxel-resistant ovarian cancer cells [43], an
increase in its basal expression has not previously been reported.
To our knowledge, the present study provides the ﬁrst evidence
of induction of Raptor expression by growth/survival factors like
mReg2. These data, schematically depicted in Fig. 10, suggest that
mReg2-induced, mTORC1-signaled, increase in basal GRP78
expression in islets may be beneﬁcial in minimizing the impact
of increased insulin secretory demand and islet cell loss triggered
by glucolipotoxicity-induced ER stress, and may contribute to
improved b-cell survival.
The tuberous sclerosis protein (TSC) complex TSC1–TSC2 inhib-
its the activities of mTORC1 and S6K. Akt phosphorylates TSC2 and
destabilizes the TSC1–TSC2 complex. This has been shown to drive
Rheb (GTPase Ras homologue renriched in brain) into the
GTP-bound active state which enables mTORC1 to phosphorylate
p70 S6K [44]. Thus Akt appears to stimulate mTORC1 activity, in
part, by relieving the inhibitory effect of TSC1–TSC2 [45,46]. It
remains to be established if mReg2 induces Akt-dependent phos-
phorylation of TSC2.
Stimulation of b-cell proliferation by Reg1 and induction of islet
cell neogenesis by INGAP have both been reported to be signaled
via cell membrane receptors [47,48]. Interestingly, Reg1 has been
reported to function both as a receptor ligand and an intracellular
protein to regulate distinct cellular signaling events [47,49,50]. We
detected the presence of mReg2 in the culture medium of
MIN6-mReg2 cells by immunoblot analysis (not shown). However,
in preliminary experiments, treatment of MIN6-VC cells with con-
ditioned medium from MIN6-mReg2 cells did not elicit signiﬁcant
change in GRP78 expression and ER stress response. This may be
due to inadequate levels of the peptide and/or loss due to proteo-
lytic degradation. These considerations warrant further studies to
conﬁrm if it acts as an intracellular regulator of Akt–mTORC1 axisor as a secreted autocrine factor through putative receptor-
mediated regulation of the Akt–mTORC1 signaling axis.
In summary, the present study provides insights into the pro-
tective role of mReg2 in insulin producing cells. It attenuates
UPR in MIN6 cells by inducing increased basal expression of
GRP78 by activating the Akt–mTORC1 signaling axis as evidenced
by the increased phosphorylation of Akt and mTOR, elevated
expression of Raptor and GbL, and enhanced basal mTORC1 kinase
activity. Inhibition of Akt or mTORC1 abrogated the ability of
mReg2 to induce GRP78. Taken together, the present ﬁndings indi-
cate that mReg2 promotes increased basal GRP78 expression via
Akt–mTORC1 signaling axis leading to the attenuation of ER
L. Liu et al. / FEBS Letters 588 (2014) 2016–2024 2023stress-induced UPR. These ﬁndings lead us to propose that induced
expression of mReg2 may promote pancreatic islet b-cell survival
by attenuating ER stress response.
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